Latest News On Prescription Drugs

Latest 素人色情片Health News Stories

Copycat Weight-Loss Drugs Are Major Players With Consumers

素人色情片Health News Original

As many as 1 in 8 American adults has tried one of the GLP-1 anti-obesity drugs, but a surprising number aren鈥檛 getting their supplies from pharma giants Novo Nordisk or Eli Lilly. Up to 30 percent of the market, by some estimates, is made up of copycat versions from compounding pharmacies. Compounding is legal, though […]

素人色情片Health News' 'What the Health?': SCOTUS Rejects Abortion Pill Challenge 鈥 For Now聽

Podcast

The Supreme Court has dismissed a challenge to the FDA鈥檚 approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of 素人色情片Health News, and Emmarie Huetteman of 素人色情片Health News join 素人色情片Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 素人色情片president and CEO Drew Altman about KFF鈥檚 new 鈥淗ealth Policy 101鈥 primer.

Weight-Loss Drugs Are So Popular They鈥檙e Headed for Medicare Negotiations

素人色情片Health News Original

The steep prices 鈥 and popularity 鈥 of Ozempic and similar weight-loss and diabetes drugs could soon make them a priority for Medicare drug price negotiations. List prices for a month鈥檚 supply of the drugs range from $936 to $1,349, according to the Peterson-素人色情片Health System Tracker. The Inflation Reduction Act President Biden signed in […]

素人色情片Health News' 'What the Health?': Abortion Access Changing Again in Florida and Arizona

Podcast

A six-week abortion ban took effect in Florida this week, dramatically restricting access to the procedure not just in the nation鈥檚 third-most-populous state but across the South. Patients from states with even more restrictive bans had been flooding in since the overturn of Roe v. Wade in 2022. Meanwhile, the CEO of the health behemoth UnitedHealth Group appeared before committees in both the House and Senate, where lawmakers grilled him about the February cyberattack on subsidiary Change Healthcare and how its ramifications are being felt months later. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of 素人色情片Health News join 素人色情片Health News鈥 Julie Rovner to discuss these stories and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.

This State Isn鈥檛 Waiting for Biden To Negotiate Drug Prices

素人色情片Health News Original

As the federal government negotiates with drugmakers to lower the price of 10 expensive drugs for Medicare patients, impatient legislators in some states are trying to go even further. Leading the pack is Colorado, where a new Prescription Drug Affordability Review Board is set to recommend an 鈥渦pper payment limit鈥 for drugs it deems unaffordable. In late […]

素人色情片Health News' 'What the Health?': The ACA Turns 14

Podcast

Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. Health and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law 鈥 and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of 素人色情片Health News join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week鈥檚 Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.

A Battle Between Drugmakers and Insurers Hits Patients in the Wallet

素人色情片Health News Original

There鈥檚 a long-running battle between insurers and drugmakers over financial assistance programs that purport to help patients afford expensive drugs. And lately, insurers have been losing ground as lawmakers, regulators and courts weigh in. The issue is whether coupons and other copay aid many patients get from drugmakers should count toward annual insurance deductibles and […]